www.neuroendocrinecancer.org.uk
Pre-Treatment Considerations:
Medications:
If you already receive somatostatin analogues (Lanreotide or Octreotide), your team may want to adjust the scheduling to fit with the recommended timing of RLT. If you have Carcinoid Syndrome or are at risk of other hormone-related crises during treatment, your team may consider adding medications at the time of RLT to reduce the risk of this occurring. For example: Carcinoid crisis prevention measures Adrenal crisis precautions (may be considered in adrenal-based NET) Following RLT, you will be advised to avoid certain types of close contact with others for between 4 and 14 days after each treatment. Arrangements may need to be made before treatment to facilitate this. For example: You may be advised against sleeping in the same bed as someone else for 7 to 14 days after each treatment. You may be advised to avoid close contact with pregnant women and/or young children for a similar period. You may be advised against using certain types of travel, for example, public transport, for a number of days after each treatment. Check with your specialist team about arrangements if you are the main carer for someone else or a pet. Check with your specialist team about returning to work or your place of study.
Made with FlippingBook Annual report maker